- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- January 2025
- 50 Pages
Global
From €2275EUR$2,499USD£1,932GBP
- Report
- January 2025
- 75 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- September 2024
- 351 Pages
Global
From €3820EUR$4,197USD£3,245GBP
- Report
- April 2025
- 450 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- April 2025
- 550 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- November 2024
- 700 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- April 2025
- 1000 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- November 2024
- 450 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- November 2024
- 650 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- November 2024
- 450 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- March 2025
- 2500 Pages +
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- March 2025
- 1500 Pages +
Global
From €4546EUR$4,995USD£3,861GBP

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders.
Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more